Radioimmunoassay of chromogranin A and free metanephrines in diagnosis of pheochromocytoma

Title:

Radioimmunoassay of chromogranin A and free metanephrines in diagnosis of pheochromocytoma

Creator:

Radovan Bílek, Tomáš Zelinka, Petr Vlček, Jaroslava Dušková, David Michalský, Novák, K., Václavíková, E., and Jiří Widimský

Identifier:

https://cdk.lib.cas.cz/client/handle/uuid:c636dcdf-f069-48db-8cbe-d94034be9d82
uuid:c636dcdf-f069-48db-8cbe-d94034be9d82
issn:0862-8408

Subject:

Fyziologie člověka a srovnávací fyziologie, feochromocytomy, paragangliomy, pheochromocytoms, paraganglioms, radioimmunoassay, chromogranin A, plasma free metanephrine, plasma free normetanephrine, 14, and 612

Type:

article, články, journal articles, model:article, and TEXT

Format:

print, bez média, and svazek

Description:

This work discusses the clinical performance of chromogranin A, free metanephrine and normetanephrine determination in plasma using a radioimmunoanalytical methods for the diagnosis of pheochromocytoma and paraganglioma. Blood samples were collected from 55 patients (46 pheochromocytomas, 9 paragangliomas). A sampling of biological materials was performed preoperatively and about one week, six months and one year after adrenal gland surgery. The comparative group without a diagnosis of pheochromocytoma/paraganglioma consisted of 36 pheochromocytoma/paraganglioma patients more than 4 months after adrenal gland surgery, and of 87 patients, 16 of them with multiple endocrine neoplasia, 9 with medullary and 5 with parafolicullar carcinoma of the thyroid gland. The rest were patients with various adrenal gland disorders. Chromogranin A, metanephrine and normetanephrine were determined in the EDTA-plasma using a radioimmunoassay kits Cisbio Bioassays, France and IBL International GmbH, Germany. Clinical sensitivity was 96 % for the combination of metanephrine and normetanephrine, and 93 % for chromogranin A. Clinical specificity was 100 % for the combination metanephrine and normetanephrine, and 96 % for chromogranin A. Falsely elevated levels of chromogranin A were observed in 1 patient with chronic renal insufficiency and 9 analyses were influenced by the administration of proton pump inhibitors. These results were excluded of CGA specificity. Both the combination of plasma free metanephrine, normetanephrine and chromogranin A as determined by radioimmunoassays, which are simple without the necessity of special laboratory material, are effective markers of pheochromocytoma or paraganglioma. Chromogranin A exerts association to malignity and all markers are associated with tumor mass., R. Bílek, T. Zelinka, P. Vlček, J. Dušková, D. Michalský, K. Novák, E. Václavíková, J. Widimský Jr., and Obsahuje bibliografii

Language:

English

Rights:

http://creativecommons.org/publicdomain/mark/1.0/
policy:public

Source:

Physiological research | 2017 Volume:66 | Number:Suppl 3

Harvested from:

CDK

Metadata only:

false